文献速递乳腺乳腺X线

数字乳腺X线摄影联合数字化乳腺断层摄影与单纯数字乳腺X线摄影用于乳腺癌筛查:Reggio Emilia断层摄影随机试验

Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.
PubMed 文献 · Radiology · 2018-06-05

在Reggio Emilia断层摄影随机试验中,既往参与筛查的45-70岁女性随机接受数字乳腺断层摄影联合数字乳腺X线摄影(DBT+DM)或单纯数字乳腺X线摄影(DM)筛查。DBT+DM组检出率为8.6/1000,DM组为4.5/1000(提高89%),两组召回率均为3.5%,DBT+DM组召回阳性预测值为24.1%,DM组为13.0%。结论认为在既往接受DM筛查的人群中,DBT+DM检出的癌症数量多90%,且召回率相似。

要点

  • DBT+DM组癌症检出率8.6/1000,DM组4.5/1000,提高89%(95%CI:31,72)。
  • 两组召回率均为3.5%,DBT+DM组召回阳性预测值24.1%,DM组13.0%(P=.0002)。
  • DBT+DM对导管原位癌检出提高180%(95%CI:1,665),对<10mm和10-19mm浸润癌分别提高94%和122%。

核心结论

  • 在既往接受DM筛查的人群中,DBT+DM检出的癌症数量比DM多90%,且召回率相似。

研究设计与样本

  • 两臂测试-治疗随机对照试验,纳入45-70岁既往参与Reggio Emilia筛查项目的女性,1:1随机分配接受DBT+DM或DM(均双体位、双读片),DBT+DM组按DBT+DM决策处理;DM+DBT组9777例,DM组9783例,平均年龄分别为56.2岁和56.3岁。

诊断标准与关键数值

  • DBT+DM组检出率8.6/1000(83/9777),DM组4.5/1000(44/9783),提高89%(95%CI:31,72);两组召回率均为3.5%;DBT+DM组召回阳性预测值24.1%,DM组13.0%(P=.0002);DBT+DM组80例癌症中72例在至少一次DBT单独读片时阳性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare digital mammography (DM) plus digital breast tomosynthesis (DBT) versus DM alone for breast cancer screening in the Reggio Emilia Tomosynthesis trial, a two-arm test-and-treat randomized controlled trial. Materials and Methods For this trial, eligible women (45-70 years old) who previously participated in the Reggio Emilia screening program were invited for mammography. Consenting women were randomly assigned 1:1 to undergo DBT+DM or DM (both of which involved two projections and double reading). Women were treated according to the decision at DBT+DM. Sensitivity, recall rate, and positive predictive value (PPV) at baseline were determined; the ratios of these rates for DBT+DM relative to DM alone were determined. Results From March 2014 to March 2016, 9777 women were recruited to the DM+DBT arm of the study, and 9783 women were recruited to the DM arm (mean age, 56.2 vs 56.3 years). Recall was 3.5% in both arms; detection was 4.5 per 1000 (44 of 9783) and 8.6 per 1000 (83 of 9777), respectively (+89%; 95% confidence interval [CI]: 31, 72). PPV of the recall was 13.0% and 24.1%, respectively (P = .0002); 72 of 80 cancers found in the DBT+DM arm and with complete DBT imaging were positive at least at one DBT-alone reading. The greater detection rate for DM+DBT was stronger for ductal carcinoma in situ (+180%, 95% CI: 1, 665); it was notable for small and medium invasive cancers, but not for large ones (+94 [95% CI: 6, 254]; +122 [95% CI: 18, 316]; -12 [95% CI: -68, 141]; for invasive cancers < 10 mm, 10-19 mm, and ≥ 20 mm, respectively). Conclusion DBT+DM depicts 90% more cancers in a population previously screened with DM, with similar recall rates.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Pattacini P, Nitrosi A, Giorgi Rossi P, et al. Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial. Radiology. 2018. PMID: 29869961. doi:10.1148/radiol.2018172119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。